The combined use of dexamethasone and oxymetazoline has a vasoconstrictive, anti-inflammatory and anti-allergic effect when applied topically in diseases of the upper respiratory tract. The main goal of this research is Evaluation of the effectiveness of Dospray® nasal spray in the treatment of persistent allergic rhinitis. The study will involve 126 patients diagnosed with allergic rhinitis: 1. Patients taking Dospray = 63 2. Patients on other alternative treatment = 63 Duration of Patient Participation - 7-10 days (duration of treatment for an individual patient).
Primary task: Overall assessment of the effectiveness of Dospray® nasal spray in the treatment of persistent allergic rhinitis. Secondary Tasks: * Symptomatic evaluation of the effectiveness of Dospray® nasal spray in the treatment of persistent allergic rhinitis; * Evaluation of the effect of Dospray® nasal spray on conjunctive symptoms in the treatment of persistent allergic rhinitis; * Evaluation of the effect of Dospray® nasal spray on the severity and frequency of nasal symptoms in the treatment of persistent allergic rhinitis; * Assessment of the quality of life before and after the use of Dospray® nasal spray in the treatment of persistent allergic rhinitis; * Safety assessment of the use of nasal spray Dospray®. Study Endpoints: 1. Dynamics of scores on the scale of the reflective Total nasal symptoms score (TNSS) \[Time: 7 days\] 2. Dynamics of scores on the scale of the individual reflective Total nasal symptoms score (iTNSS) \[Time: 7 days\] 3. Dynamics of scores on the scale of the reflective Total ocular symptom score (rTOSS) 4. Changes in Visual Analogue Scale (VAS) scores for the severity and frequency of nasal symptoms \[Time: 7 days\]. 5. Dynamics of scores on the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) scores \[Time: 7 days\] 6. Adverse reactions \[Time: 7 days\] Number of yellow cards.
Study Type
OBSERVATIONAL
Enrollment
126
non-interventional study
Allergo Clinic Medical Center
Almaty, Kazakhstan
RECRUITINGLLP LOR-Center Ai-Medicus
Almaty, Kazakhstan
RECRUITINGDynamics of scores on the scale of the reflective Total nasal symptoms score (TNSS)
Time frame: [Time: 7 days]
Dynamics of scores on the scale of the individual reflective Total nasal symptoms score (iTNSS)
Time frame: [Time: 7 days]
Dynamics of scores on the scale of the reflective Total ocular symptom score (rTOSS)
Time frame: [Time: 7 days]
Changes in Visual Analogue Scale (VAS) scores for the severity and frequency of nasal symptoms.
Time frame: [Time: 7 days]
Dynamics of scores on the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) scores
Time frame: [Time: 7 days]
Adverse reactions - Number of yellow cards.
Time frame: [Time: 7 days]
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.